版本:
中国

BRIEF-Tetraphase Pharmaceuticals completes enrollment of ignite4 phase 3 clinical trial of eravacycline in complicated intra-abdominal infections

April 3 Tetraphase Pharmaceuticals Inc

* Tetraphase Pharmaceuticals completes enrollment of ignite4 phase 3 clinical trial of eravacycline in complicated intra-abdominal infections

* Tetraphase Pharmaceuticals Inc says expects to report top-line data from ignite4 phase 3 clinical trial in Q3 of 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐